224 related articles for article (PubMed ID: 32523628)
81. Barrett's esophagus: review of diagnosis and treatment.
Sappati Biyyani RS; Chak A
Gastroenterol Rep (Oxf); 2013 Jul; 1(1):9-18. PubMed ID: 24759662
[TBL] [Abstract][Full Text] [Related]
82. Endoscopic therapies for Barrett's neoplasia.
Watson TJ
J Thorac Dis; 2014 May; 6 Suppl 3(Suppl 3):S298-308. PubMed ID: 24876934
[TBL] [Abstract][Full Text] [Related]
83. Endoscopic management of Barrett's and early oesophageal neoplasia.
Lipman G; Haidry RJ
Frontline Gastroenterol; 2017 Apr; 8(2):138-142. PubMed ID: 28839898
[TBL] [Abstract][Full Text] [Related]
84. Endoscopic assessment and management of early esophageal adenocarcinoma.
Hammoud GM; Hammad H; Ibdah JA
World J Gastrointest Oncol; 2014 Aug; 6(8):275-88. PubMed ID: 25132925
[TBL] [Abstract][Full Text] [Related]
85. ENDOSCOPIC TREATMENT OF ESOPHAGEAL NEOPLASIA: A DECADE OF EVOLUTION.
Shaheen NJ
Trans Am Clin Climatol Assoc; 2020; 131():297-314. PubMed ID: 32675869
[TBL] [Abstract][Full Text] [Related]
86. Patient decision-making and clinical outcomes following endoscopic therapy or esophagectomy for Barrett's neoplasia.
Lockwood R; Ozanne E; Hur C; Yachimski P
Endosc Int Open; 2017 Nov; 5(11):E1128-E1135. PubMed ID: 29124122
[TBL] [Abstract][Full Text] [Related]
87. Impact of the development of an endoscopic eradication program for Barrett's esophagus with high grade dysplasia or early adenocarcinoma on the frequency of surgery.
Chilukuri P; Gromski MA; Johnson CS; Ceppa DKP; Kesler KA; Birdas TJ; Rieger KM; Fatima H; Kessler WR; Rex DK; Al-Haddad M; DeWitt JM
Endosc Int Open; 2018 Sep; 6(9):E1085-E1092. PubMed ID: 30211296
[No Abstract] [Full Text] [Related]
88. Cryospray ablation using pressurized CO2 for ablation of Barrett's esophagus with early neoplasia: early termination of a prospective series.
Verbeek RE; Vleggaar FP; Ten Kate FJ; van Baal JW; Siersema PD
Endosc Int Open; 2015 Apr; 3(2):E107-12. PubMed ID: 26135648
[TBL] [Abstract][Full Text] [Related]
89. Update on applications of endoscopic cryotherapy in the gastrointestinal tract.
Enslin S; Kaul V
Curr Opin Gastroenterol; 2024 Apr; ():. PubMed ID: 38662539
[TBL] [Abstract][Full Text] [Related]
90. Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia.
Harris S; Fasullo M; Smallfield G; Shah T
VideoGIE; 2021 May; 6(5):239-242. PubMed ID: 34027259
[TBL] [Abstract][Full Text] [Related]
91. Retrospective, observational, cross-sectional study of detection of recurrent Barrett's esophagus and dysplasia in post-ablation patients with adjunctive use of wide-area transepithelial sample (WATS-3D).
Fatima H; Wajid M; Hamade N; Han Y; Kessler W; Dewitt J; Rex D; Imperiale T
Ann Gastroenterol; 2022; 35(2):113-118. PubMed ID: 35479593
[TBL] [Abstract][Full Text] [Related]
92. Patients' values and preferences regarding endoscopic therapy for Barrett's esophagus: A cross-sectional survey study.
Qumseya BJ; Estores D; Gorripati V; Liu N; Qumseya A
DEN Open; 2024 Apr; 4(1):e341. PubMed ID: 38343422
[TBL] [Abstract][Full Text] [Related]
93. Glycomic expression in esophageal disease.
Mohanty S; Tsiouris A; Hammoud Z
Metabolites; 2012 Nov; 2(4):1004-11. PubMed ID: 24957772
[TBL] [Abstract][Full Text] [Related]
94. Salvage nitrous oxide cryotherapy of refractory colon neoplasia embedded within an endoclip.
Trindade AJ; Benias PC; Cerulli MA
Endosc Int Open; 2018 Dec; 6(12):E1410-E1412. PubMed ID: 30505934
[No Abstract] [Full Text] [Related]
95. Interventional Therapy of Esophageal Cancer.
Mao A
Gastrointest Tumors; 2016 Oct; 3(2):59-68. PubMed ID: 27904858
[TBL] [Abstract][Full Text] [Related]
96. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later?
Jones B; Wani S
Curr Gastroenterol Rep; 2020 Dec; 22(12):61. PubMed ID: 33277663
[TBL] [Abstract][Full Text] [Related]
97. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia.
Choi WT; Lauwers GY; Montgomery EA
Mod Pathol; 2022 Aug; 35(8):1000-1012. PubMed ID: 35260826
[TBL] [Abstract][Full Text] [Related]
98. The role of ablation in the treatment of dysplastic Barrett's esophagus.
Sullivan R; Mulki R; Peter S
Ther Adv Gastrointest Endosc; 2021; 14():26317745211049967. PubMed ID: 34708203
[TBL] [Abstract][Full Text] [Related]
99. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue.
Bowman CJ; Zhang R; Balitzer D; Wang D; Rabinovitch PS; Kővári BP; Mattis AN; Kakar S; Lauwers GY; Choi WT
Mod Pathol; 2021 Oct; 34(10):1889-1900. PubMed ID: 34108638
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
